opioid dependence

Abstract Objective Methadone coverage is poor in many countries due in part to methadone induction being possible only in specialized care (SC). This multicenter pragmatic trial compared the effectiveness of methadone treatment between two...

ISSUP Kazakhstan presents Its webinar on the principles of harm reduction for patients. This webinar delves deeper into opioid agonist maintenance therapy.

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...

Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment...

Abstract Importance: Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine. Objective: To compare patient satisfaction between...

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021...

Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) is an educational initiative that aims to improve opioid dependence healthcare through a variety of programmes IOTOD host an annual conference, and following the event they...